Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT01717131

Active, not recruiting

Axillary Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node

Invasive Breast Cancer
NCT03480659

Terminated

Detection of Breast Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC

Breast Cancer | Breast Cancer Female
NCT02599363

Completed

A Trial of Ribocilcib (LEE011) and Weekly Paclitaxel in Patients With Rb+ Advanced Breast Cancer

Advanced Breast Cancer
NCT01074814

Completed

Pilot Study Using Molecular Profiling to Find Potential Targets & Select Treatments for Pts With Met br ca (Side-Out)

Metastatic Breast Cancer
NCT03939156

Active, not recruiting

Patients' Preferences for Adjuvant Endocrine Therapy in Early Breast Cancer (ELENA)

Breast Cancer | Endocrine Breast Diseases
NCT05376644

Completed

Molecular Imaging of HER2 Expression in HER2-positive Breast Cancer Using 99mTc-ADAPT6 vs 99mTc-DARPinG3

Breast Cancer Female
NCT03065621

Completed

Neoadjuvant Biomarker ResearcH Study of Palbociclib Combined With Endocrine Therapy in Estrogen Receptor Positive/HER2 Negative Breast CAncer (NeoRHEA) (NeoRHEA)

Breast Cancer Female
NCT02027376

Completed

Study of LDE225 (Sonidegib) in Combination With Docetaxel in Triple Negative (TN) Advanced Breast Cancer (ABC) Patients (EDALINE)

Advanced Breast Cancer
NCT00608972

Completed

Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer

Metastatic Breast Cancer
NCT04770129

Completed

Real-World Data on Clinical Characteristics, Demographics, and Outcomes of Patients With Metastatic Breast Cancer in Turkey

Metastatic Breast Cancer
NCT03517813

Completed

CESM ABMR Breast Cancer Screening Trial

Breast Cancer Screening
NCT02237469

Active, not recruiting

Prone Breast Radiotherapy Treatment Planning Observational Study (HUGProne)

Breast Cancer Female
NCT04001621

Active, not recruiting

Pyrotinib in Combination With Capecitabine in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer

Metastatic Breast Cancer
NCT03863223

Active, not recruiting

A Study of Pyrotinib in Combination With Trastuzumab and Docetaxel in Patients With HER2 Metastatic Breast Cancer

Metastatic Breast Cancer
NCT03473639

Completed

A Pilot Study of the Combination of Entinostat With Capecitabine in High Risk Breast Cancer After Neo-adjuvant Therapy (Breast49)

Breast Cancer | Metastatic Breast Cancer
NCT03979729

Completed

Breast Cancer Screening for Underserved Women: Comparing Outcomes and Lowering Recall Rates With 3D- vs. 2D-mammography

Breast Cancer Screening
NCT04170465

Completed

Role of Adding Metformin to Neoadjuvant Chemotherapy in Patients With Breast Cancer (METNEO) (METNEO)

Breast Cancer Female
NCT02506556

Completed

Phosphatidylinositol 3-kinase (PI3K) Alpha iNhibition In Advanced Breast Cancer (PIKNIC)

Metastatic Breast Cancer
NCT01498458

Completed

Pazopanib in Combination With Capecitabine in Patients With Metastatic Breast Cancer (PazoX)

Metastatic Breast Cancer
NCT03045653

Completed

Efficacy of High Dose Tamoxifen to Advanced Hormone Receptor-High Expressed Breast Cancer

Breast Cancer Metastatic
NCT03608865

Completed

Durvalumab (MEDI4736) and Tremelimumab in Hormone Receptor-positive, Hypermutated Metastatic Breast Cancer Identified by Whole Exome Sequencing

Metastatic Breast Cancer
NCT05153135

Completed

Description of Treatment Patterns and Description and Comparison of Healthcare Resource Utilization and Costs of Women With Metastatic HR+/HER2- Breast Cancer Treated With CDK4/6 Inhibitors

Metastatic Breast Cancer
NCT05141240

Completed

A Real-world Analysis of Concomitant Medication Use Among Metastatic Breast Cancer Patients Treated With CDK4/6 Inhibitors

Metastatic Breast Cancer
NCT04990934

Completed

Transitioning Care: Perspectives of Older Women With Early Breast Cancer on Current Telemedicine Modalities

Breast Cancer | Breast Cancer Female
NCT04143282

Completed

Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment

Metastatic Breast Cancer
NCT03863522

Terminated

Automated Method for Breast Cancer Detection

Breast Cancer Diagnosis
NCT02001974

Completed

Pilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)

Metastatic Breast Cancer
NCT04312347

Completed

Tamoxifen Dose Adjustment on Indonesian Female ER+ Breast Cancer Patients Based on CYP2D6 Genotype and Endoxifen Levels

ER+ Breast Cancer
NCT01989676

Completed

A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02)

Metastatic Breast Cancer
NCT03573661

Completed

A Pilot Multi-Institutional Study to Evaluate the Accuracy of a Breast Cancer Locator in Patients With Palpable Cancers (BCL)

Palpable Breast Cancer
NCT03051672

Terminated

Phase II PEMBROLIZUMAB + PALLIATIVE RADIOTHERAPY IN BC

Metastatic Breast Cancer
NCT01310231

Completed

A Trial of Standard Chemotherapy With Metformin (vs Placebo) in Women With Metastatic Breast Cancer

Metastatic Breast Cancer
NCT02924883

Completed

A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine in Combination With Atezolizumab or Atezolizumab-Placebo in Participants With Human Epidermal Growth Factor-2 (HER2) Positive Locally Advanced or Metastatic Breast Cancer (BC) Who Received Prior Trastuzumab and Taxane Based Therapy (KATE2)

Metastatic Breast Cancer
NCT01323530

Completed

A Confirmation Study of Eribulin in Combination With Capecitabine

Metastatic Breast Cancer
NCT00958971

Completed

Safety and Efficacy of TKI258 in FGFR1 Amplified and Non-amplified Metastatic HER2 Negative Breast Cancer

Metastatic Breast Cancer
NCT04654195

Unknown

Study of ABCB1,SLC22A16 Drug Transporter Genes and Doxorubicin and Cyclophosphamide Toxicity in Brest Cancer Patient

Breast Cancer Patients
NCT02511639

Completed

Maintenance Aromatase Inhibitors (AIs)+ Everolimus vs AIs in Hormone Receptor Positive Metastatic Breast Cancer Patients (MAIN-A)

Breast Cancer Metastatic
NCT03902977

Terminated

Effect of Quilting Sutures on Post-operative Drainage After Mastectomy and/or Axillary Lymph Node Dissection (Quilting)

Breast Cancer Female
NCT04581967

Unknown

Study of CYP2C19 and ALDH3A1 Polymorphisms in Breast Cancer Patients

Breast Cancer Patients
NCT03241810

Terminated

Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer (SHERBOC)

Metastatic Breast Cancer
NCT01818999

Withdrawn

Ixabepilone and SBRT For Metastatic Breast Cancer

METASTATIC BREAST CANCER
NCT00905021

Terminated

Exemestane With Sunitinib (SUTENT®) in Metastatic Breast Cancer (EXTENT)

Metastatic Breast Cancer
NCT04480229

Completed

Telenursing and Breast Cancer: The Turkish Case

Breast Cancer Female
NCT03195192

Completed

Utilizing Multiomic Advanced Diagnostics to Identify CDK 4/6 Inhibitor Response Predictors and a Post-treatment Multiomic Signature for Patients With ER+/HER2- Metastatic Breast Cancer

Metastatic Breast Cancer
NCT00337103

Completed

E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes

Metastatic Breast Cancer
NCT01792050

Completed

Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer

Metastatic Breast Cancer
NCT01314833

Completed

Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy

Primary Breast Cancer
NCT04127019

Completed

Adjuvant 6 Cycles of Docetaxel and Cyclophosphamide or 3 Cycles of Cyclophosphamide/Epirubicin/Fluorouracil Followed by 3 Cycles of Docetaxel Versus 4 Cycles of Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Operable Breast Cancer (MASTER)

Primary Breast Cancer
NCT04102722

Unknown

Safety and Performance of the Multi-Modal UltraSound Tomography (MUST) Device in Breast Cancer Screening

Breast Cancer Screening
NCT00204776

Completed

XELOX for Metastatic Breast Cancer

Metastatic Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations